Solbar Thirty Spf 30 Cream
FDA Label NDC 0096-0685

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Person And Covey for the product Solbar Thirty Spf 30 (NDC 0096-0685). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding purpose, otc - active ingredient section, inactive ingredient section, indications and use, dosage and administration:, keep out of reach of children:, warnings, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Sun screen.

Otc - Active Ingredient Section

Homosalate

Octinoxate

Oxybenzone

Avobenzone

Octocrylene

Inactive Ingredient Section

Alcohol

Isobutyl Stearate

Cyclomethicone

PVP/Eicosene Copolymer

Dimethicone

Klucel Hydroxypropylcellulose

Acrylates/Octylacrylamide Copolymer

Indications And Use

Helps prevent sunburn. If used as directed with other sun protection measures, decreases the risk of skin cancer and early skin aging caused by the sun.

Dosage And Administration:

Apply liberally and evenly to all sun exposed areas of DRY skin 15 minutes before sun exposure. Reapply after 80 minutes of swimming or sweating and immediately after towel drying. Apply at least every 2 hours. For children under 6 months, ask a physician.

Keep Out Of Reach Of Children:

Yes. If swallowed, get medical help or contact a Poison Control Center right away.

Warnings

 For external use only. Do not use on damaged or broken skin. Keep out of eyes. Rinse eyes thoroughly with water to remove. Stop use and ask a physician if rash or irritation develops and lasts. Store away from excessive heat and direct sun.

Principal Display Panel

Solbar Thirty SPF30.jpg

* Please review the disclaimer below.